Tuesday, 21 August 2018

Announcement

HALFYR: TRU: Clarification - TruScreen Interim Results - SalesTimeline

14 Dec 2017 15:36NZX
NZX and Media Release
14 December, 2017

NZX Limited
WELLINGTON

TRUSCREEN INTERIM RESULTS TO 30 SEPTEMBER 2017

Clarification

Timing of sales for Financial Year Ending 31 March, 2018

TruScreen wishes to clarify the statement made in its results announcement
today regarding the timing of the increase in sales.

The reference to the ''final quarter of FY18'' refers to the final quarter of
the financial year ending 31 March, 2018.  That is, January to March, 2018.

ENDS

For more information visit www.truscreen.com or contact:
Martin Dillon
TruScreen Chief Executive Officer
Email: martindillon@truscreen.com Media Liaison
Jackie Ellis
Email: jackie@ellisandco.co.nz
Phone: +64 27 246 2505

About TruScreen:
TruScreen''s real time cervical cancer technology utilises a digital wand
which is placed on the surface of the cervix to measure electrical and
optical signals from the surrounding tissue. A sophisticated proprietary
algorithm framework distinguishes between normal and abnormal (cancerous and
precancerous) tissue to identify precancerous change, or cervical
intraepithelial neoplasia (CIN).  A Single Use Sensor (SUS) is used for each
patient to protect against cross-infection
End CA:00311980 For:TRU    Type:HALFYR     Time:2017-12-14 15:36:33
Views: 102
TruScreen Limited Ordinary Shares
 0.1850 Change:
0.01
2.63%
 
Open:0.1900 
High:0.1900 
Low:0.1900 
Volume:22,054 
Last Traded:07/02/18 09:15:21 
Bid:0.1850 
Ask:0.1850 
52-Wk High:0.2300 
52-Wk Low:0.1200